Abstract:Purpose: To examine the effects of the alkylating anticancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on Na-23 MRI and the water apparent diffusion coefficient(ADC) in subcutaneously- (sc-) implanted 9L glioma in rats.Materials and Methods: Na-23 MRI and H-1 water ADC measurements were performed on sham-treated control (N = 6) and BCNU-treated (N = 15) Fisher rats one day,before, BCNU injection and then one, three, and five day glier BCNU injection.Results: The BCNU-treated tumors were divided into responsive (R-BCNU) and BCNU-nonresponsive (NRBCNU) groups, depending on the tumor volume changes that occurred after therapy. The pretreatment Na-23 MRI signal intensity (SI) and water ADC values were higher in RBcNu tumors compared to NRBCNU tumors. Na-23 MRI SI and water ADC increased with tumor growth in control and NRBCNU groups, but these changes were interrupted by BCNU therapy in R-BCNU group.Conclusion: Na-23 MRI and water ADC measurements may be useful for predicting and monitoring response to chemotherapy in some tumors. However, the changes that occured in Na-23 MRI SI and water ADC in sc-implanted tumors are in contrast to previously published results for BCNU therapy of orthotopic 9L tumors. This may have important implications for monitoring therapy response in tumors.

Predicting and Monitoring Response to Chemotherapy by 1,3‐bis(2‐chloroethyl)‐1‐nitrosourea in Subcutaneously Implanted 9L Glioma Using the Apparent Diffusion Coefficient of Water and 23na MRI